FarFaR - Pharmacy Repository
University of Belgrade, Faculty of Pharmacy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Revealing the role of high-density lipoprotein in colorectal cancer

Thumbnail
2021
Revealing_the_Role_pub_2021.pdf (1.132Mb)
Authors
Zeljković, Aleksandra
Vekić, Jelena
Mihajlović, Marija
Gojković, Tamara
Vladimirov, Sandra
Zeljković, Dejan
Spasojević-Kalimanovska, Vesna
Trifunović, Bratislav
Article (Published version)
Metadata
Show full item record
Abstract
Colorectal cancer (CRC) is a highly prevalent malignancy with multifactorial etiology,which includes metabolic alterations as contributors to disease development. Studies have shownthat lipid status disorders are involved in colorectal carcinogenesis. In line with this, previous studieshave also suggested that the serum high-density lipoprotein cholesterol (HDL-C) level decreases inpatients with CRC, but more recently, the focus of investigations has shifted toward the explorationof qualitative properties of HDL in this malignancy. Herein, a comprehensive overview of availableevidences regarding the putative role of HDL in CRC will be presented. We will analyze existingfindings regarding alterations of HDL-C levels but also HDL particle structure and distribution inCRC. In addition, changes in HDL functionality in this malignancy will be discussed. Moreover,we will focus on the genetic regulation of HDL metabolism, as well as the involvement of HDL indisturbances of cholesterol traffi...cking in CRC. Finally, possible therapeutic implications related toHDL will be presented. Given the available evidence, future studies are needed to resolve all raisedissues concerning the suggested protective role of HDL in CRC, its presumed function as a biomarker,and eventual therapeutic approaches based on HDL.

Keywords:
Cholesterol trafficking / Colorectal cancer / Genetic background / HDL functional properties / HDL particle distribution / High-density lipoprotein / Therapeutic implications
Source:
International Journal of Molecular Sciences, 2021, 22, 7
Publisher:
  • MDPI AG
Funding / projects:
  • Ministry of Education, Science and Technological Development, Republic of Serbia, Grant no. 200161 (University of Belgrade, Faculty of Pharmacy) (RS-200161)

DOI: 10.3390/ijms22073352

ISSN: 1422-0067

WoS: 000638616800001

Scopus: 2-s2.0-85103044175
[ Google Scholar ]
10
2
URI
https://farfar.pharmacy.bg.ac.rs/handle/123456789/3813
Collections
  • Radovi istraživača / Researchers’ publications
Institution/Community
Pharmacy
TY  - JOUR
AU  - Zeljković, Aleksandra
AU  - Vekić, Jelena
AU  - Mihajlović, Marija
AU  - Gojković, Tamara
AU  - Vladimirov, Sandra
AU  - Zeljković, Dejan
AU  - Spasojević-Kalimanovska, Vesna
AU  - Trifunović, Bratislav
PY  - 2021
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3813
AB  - Colorectal cancer (CRC) is a highly prevalent malignancy with multifactorial etiology,which includes metabolic alterations as contributors to disease development. Studies have shownthat lipid status disorders are involved in colorectal carcinogenesis. In line with this, previous studieshave also suggested that the serum high-density lipoprotein cholesterol (HDL-C) level decreases inpatients with CRC, but more recently, the focus of investigations has shifted toward the explorationof qualitative properties of HDL in this malignancy. Herein, a comprehensive overview of availableevidences regarding the putative role of HDL in CRC will be presented. We will analyze existingfindings regarding alterations of HDL-C levels but also HDL particle structure and distribution inCRC. In addition, changes in HDL functionality in this malignancy will be discussed.  Moreover,we will focus on the genetic regulation of HDL metabolism, as well as the involvement of HDL indisturbances of cholesterol trafficking in CRC. Finally, possible therapeutic implications related toHDL will be presented. Given the available evidence, future studies are needed to resolve all raisedissues concerning the suggested protective role of HDL in CRC, its presumed function as a biomarker,and eventual therapeutic approaches based on HDL.
PB  - MDPI AG
T2  - International Journal of Molecular Sciences
T1  - Revealing the role of high-density lipoprotein in colorectal cancer
VL  - 22
IS  - 7
DO  - 10.3390/ijms22073352
ER  - 
@article{
author = "Zeljković, Aleksandra and Vekić, Jelena and Mihajlović, Marija and Gojković, Tamara and Vladimirov, Sandra and Zeljković, Dejan and Spasojević-Kalimanovska, Vesna and Trifunović, Bratislav",
year = "2021",
abstract = "Colorectal cancer (CRC) is a highly prevalent malignancy with multifactorial etiology,which includes metabolic alterations as contributors to disease development. Studies have shownthat lipid status disorders are involved in colorectal carcinogenesis. In line with this, previous studieshave also suggested that the serum high-density lipoprotein cholesterol (HDL-C) level decreases inpatients with CRC, but more recently, the focus of investigations has shifted toward the explorationof qualitative properties of HDL in this malignancy. Herein, a comprehensive overview of availableevidences regarding the putative role of HDL in CRC will be presented. We will analyze existingfindings regarding alterations of HDL-C levels but also HDL particle structure and distribution inCRC. In addition, changes in HDL functionality in this malignancy will be discussed.  Moreover,we will focus on the genetic regulation of HDL metabolism, as well as the involvement of HDL indisturbances of cholesterol trafficking in CRC. Finally, possible therapeutic implications related toHDL will be presented. Given the available evidence, future studies are needed to resolve all raisedissues concerning the suggested protective role of HDL in CRC, its presumed function as a biomarker,and eventual therapeutic approaches based on HDL.",
publisher = "MDPI AG",
journal = "International Journal of Molecular Sciences",
title = "Revealing the role of high-density lipoprotein in colorectal cancer",
volume = "22",
number = "7",
doi = "10.3390/ijms22073352"
}
Zeljković, A., Vekić, J., Mihajlović, M., Gojković, T., Vladimirov, S., Zeljković, D., Spasojević-Kalimanovska, V.,& Trifunović, B.. (2021). Revealing the role of high-density lipoprotein in colorectal cancer. in International Journal of Molecular Sciences
MDPI AG., 22(7).
https://doi.org/10.3390/ijms22073352
Zeljković A, Vekić J, Mihajlović M, Gojković T, Vladimirov S, Zeljković D, Spasojević-Kalimanovska V, Trifunović B. Revealing the role of high-density lipoprotein in colorectal cancer. in International Journal of Molecular Sciences. 2021;22(7).
doi:10.3390/ijms22073352 .
Zeljković, Aleksandra, Vekić, Jelena, Mihajlović, Marija, Gojković, Tamara, Vladimirov, Sandra, Zeljković, Dejan, Spasojević-Kalimanovska, Vesna, Trifunović, Bratislav, "Revealing the role of high-density lipoprotein in colorectal cancer" in International Journal of Molecular Sciences, 22, no. 7 (2021),
https://doi.org/10.3390/ijms22073352 . .

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB